JP2020511481A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020511481A5 JP2020511481A5 JP2019551449A JP2019551449A JP2020511481A5 JP 2020511481 A5 JP2020511481 A5 JP 2020511481A5 JP 2019551449 A JP2019551449 A JP 2019551449A JP 2019551449 A JP2019551449 A JP 2019551449A JP 2020511481 A5 JP2020511481 A5 JP 2020511481A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- variable domain
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762475036P | 2017-03-22 | 2017-03-22 | |
| US201762475032P | 2017-03-22 | 2017-03-22 | |
| US62/475,032 | 2017-03-22 | ||
| US62/475,036 | 2017-03-22 | ||
| US15/871,802 | 2018-01-15 | ||
| US15/871,802 US20180142019A1 (en) | 2016-10-21 | 2018-01-15 | Therapeutic cd47 antibodies |
| PCT/US2018/023860 WO2018175790A1 (en) | 2017-03-22 | 2018-03-22 | Combination therapy for the treatment of solid and hematological cancers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020511481A JP2020511481A (ja) | 2020-04-16 |
| JP2020511481A5 true JP2020511481A5 (enExample) | 2021-05-06 |
| JP7170331B2 JP7170331B2 (ja) | 2022-11-14 |
Family
ID=63585757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019551449A Active JP7170331B2 (ja) | 2017-03-22 | 2018-03-22 | 固形及び血液癌の治療のための併用療法 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3600393A4 (enExample) |
| JP (1) | JP7170331B2 (enExample) |
| CN (1) | CN111148535A (enExample) |
| AU (1) | AU2018240377A1 (enExample) |
| CA (1) | CA3057139A1 (enExample) |
| SG (1) | SG11201908602UA (enExample) |
| WO (1) | WO2018175790A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2015122228A (ru) | 2012-12-12 | 2017-01-19 | Васкулокс Инк. | Терапевтические антитела к CD47 |
| US9221908B2 (en) | 2012-12-12 | 2015-12-29 | Vasculox, Inc. | Therapeutic CD47 antibodies |
| WO2017049251A2 (en) | 2015-09-18 | 2017-03-23 | Tioma Therapeutics, Inc. | Therapeutic cd47 antibodies |
| WO2018075960A1 (en) | 2016-10-21 | 2018-04-26 | Tioma Therapeutics, Inc. | Therapeutic cd47 antibodies |
| WO2020114399A1 (zh) * | 2018-12-03 | 2020-06-11 | 上海开拓者生物医药有限公司 | Cd47抗体及其制备方法和应用 |
| EP3969120A4 (en) * | 2019-05-16 | 2023-09-13 | Arch Oncology, Inc. | THERAPEUTIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER IN COMBINATION WITH ANALOGUES OF INTERLEUKIN PROTEINS |
| US20200400662A1 (en) | 2019-06-07 | 2020-12-24 | ALX Oncology Inc. | Methods and reagents for reducing the interference of drugs that bind cd47 in serological assays |
| CA3158622A1 (en) * | 2019-10-23 | 2021-04-29 | Arch Oncology, Inc. | Combination therapy for the treatment of solid and hematological cancers |
| US11702474B2 (en) | 2019-12-17 | 2023-07-18 | Pfizer Inc. | Antibodies specific for CD47, PD-L1, and uses thereof |
| EP4190813A4 (en) * | 2020-07-31 | 2025-02-12 | Bio-Thera Solutions, Ltd. | CD47 ANTIBODIES AND THEIR APPLICATION |
| US20220196651A1 (en) | 2020-12-06 | 2022-06-23 | ALX Oncology Inc. | Multimers for reducing the interference of drugs that bind cd47 in serological assays |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7696325B2 (en) * | 1999-03-10 | 2010-04-13 | Chugai Seiyaku Kabushiki Kaisha | Polypeptide inducing apoptosis |
| CA2545166A1 (en) * | 2003-11-11 | 2005-05-19 | Chugai Seiyaku Kabushiki Kaisha | Humanized anti-cd47 antibody |
| RU2531758C2 (ru) * | 2008-02-11 | 2014-10-27 | Куретек Лтд. | Моноклональные антитела для лечения опухолей |
| BR112012017642A2 (pt) * | 2010-01-21 | 2016-04-12 | Immunogen Inc | composições e métodos para tratamento de câncer de ovário |
| EA034778B1 (ru) * | 2012-02-06 | 2020-03-19 | Инхибркс, Инк. | Антитела к cd47 и способы их применения |
| EP2744830A4 (en) * | 2012-06-21 | 2015-06-17 | Compugen Ltd | LSR ANTIBODIES AND USES THEREOF FOR THE TREATMENT OF CANCER |
| US9221908B2 (en) * | 2012-12-12 | 2015-12-29 | Vasculox, Inc. | Therapeutic CD47 antibodies |
| JP2016507555A (ja) * | 2013-02-06 | 2016-03-10 | インヒブルクス エルピー | 血小板非減少性かつ赤血球非減少性ｃｄ４７抗体及びその使用方法 |
| WO2017049251A2 (en) * | 2015-09-18 | 2017-03-23 | Tioma Therapeutics, Inc. | Therapeutic cd47 antibodies |
-
2018
- 2018-03-22 AU AU2018240377A patent/AU2018240377A1/en not_active Abandoned
- 2018-03-22 CN CN201880028490.2A patent/CN111148535A/zh active Pending
- 2018-03-22 EP EP18771103.1A patent/EP3600393A4/en not_active Withdrawn
- 2018-03-22 SG SG11201908602U patent/SG11201908602UA/en unknown
- 2018-03-22 JP JP2019551449A patent/JP7170331B2/ja active Active
- 2018-03-22 CA CA3057139A patent/CA3057139A1/en active Pending
- 2018-03-22 WO PCT/US2018/023860 patent/WO2018175790A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018536624A5 (enExample) | ||
| JP7608164B2 (ja) | 抗体－薬物コンジュゲートとｐａｒｐ阻害剤の組み合わせ | |
| JP6130871B2 (ja) | Ｃｄ３８を特異的に認識する抗体とビンクリスチンとを含有する抗腫瘍組合せ | |
| JP2024037894A5 (enExample) | ||
| JP6215429B2 (ja) | Ｃｄ３８を特異的に認識する抗体とシクロホスファミドとを含有する抗腫瘍組合せ | |
| JP2018534933A5 (enExample) | ||
| HRP20201939T1 (hr) | Anti-c10orf54 antitijela i njihova primjena | |
| RU2014108043A (ru) | Фармацевтическая композиция для лечения и/или профилактики злокачественной опухоли | |
| RU2014108049A (ru) | Фармацевтическая композиция для лечения и/или профилактики злокачественной опухоли | |
| RU2019138337A (ru) | Конъюгаты на основе антитела, содержащие агонист toll-подобного рецептора, и виды комбинированной терапии | |
| JP2011046732A5 (enExample) | ||
| JP2017535257A5 (enExample) | ||
| IL265541B2 (en) | Bispecific antibodies and compounds containing them for the treatment of cancer | |
| RU2011111746A (ru) | Композиции рекомбинантных антител против рецептора эпидермального фактора роста | |
| JP2017529838A5 (enExample) | ||
| IL278574B1 (en) | Glycan-interacting compounds and methods of use | |
| HRP20230517T1 (hr) | Kombinacija anti-pd-1 antitijela i radijacijske terapije za liječenje raka | |
| HRP20160212T1 (hr) | Antitijela za terapiju kancera koji eksprimira klaudin 6 | |
| RU2013152960A (ru) | Анти-cd40-антитела и способы применения | |
| RU2014106671A (ru) | Варианты гуманизированных иммуномодулирующих моноклональных антител | |
| HRP20171758T1 (hr) | Kombinacija dr5 agonista i anti-pd-1 antagonista i načini primjene | |
| JP2019500020A5 (enExample) | ||
| RU2014101669A (ru) | Агенты, связывающие белки r-спондины (rspo), и способы их применения | |
| JP2017519759A5 (enExample) | ||
| RU2008101772A (ru) | Антагонисты рецепторов для лечения метастатического рака |